FDA finally grants emergency use authorization to Pfizer's Paxlovid, a protease inhibitor which may dramatically reduce hospitalizations for people diagnosed with COVID-19

 From the story:

The U.S. has purchased 10 million courses of Pfizer’s treatment, Paxlovid, in a $5 billion deal. President Joe Biden said in November that his administration is working to ensure that the treatments are free and accessible. Biden said last month that delivery would start by the New Year and continue through 2022.  

Merry Christmas.